NEW ISSUE

Volume 67, Issue 1 / 2019 Available Online

Review Articles

Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer
Koseoglu, Mehmet Murat | Norambuena, Andrés | Sharlow, Elizabeth R. | Lazo, John S. | Bloom, George S.

Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
Almansoub, Hasan A.M.M. | Tang, Hui | Wu, Ying | Wang, Ding-Qi | Mahaman, Yacoubou Abdoul Razak | Wei, Na | Almansob, Yusra A. M. | He, Wei | Liu, Dan

Sex Differences in Alzheimer’s Disease: Where Do We Stand?
Medeiros, André de Macêdo | Silva, Regina Helena

Other Content

Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies
Rizzo, Giovanni | De Blasi, Roberto | Capozzo, Rosa | Tortelli, Rosanna | Barulli, Maria Rosaria | Liguori, Rocco | Grasso, Daniela | Logroscino, Giancarlo

Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment
Pappas, Colleen | Small, Brent J. | Andel, Ross | Laczó, Jan | Parizkova, Martina | Ondrej, Lerch | Hort, Jakub

Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project
Zammit, Andrea R. | Muniz-Terrera, Graciela | Katz, Mindy J. | Hall, Charles B. | Ezzati, Ali | Bennett, David A. | Lipton, Richard B.

Astrocyte- and Microglia-Specific Mitochondrial DNA Deletions Levels in Sporadic Alzheimer’s Disease
Strobel, Sabrina | Grünblatt, Edna | Heinsen, Helmut | Riederer, Peter | Espach, Thomas | Meder, Michael | Monoranu, Camelia-Maria

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR – Open Access
Schwarz, Christopher G. | Gunter, Jeffrey L. | Lowe, Val J. | Weigand, Stephen | Vemuri, Prashanthi | Senjem, Matthew L. | Petersen, Ronald C. | Knopman, David S. | Jack Jr, Clifford R.

Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study
Hvidsten, Lara | Engedal, Knut | Selbæk, Geir | Wyller, Torgeir Bruun | Benth, Jūratė Šaltytė | Kersten, Hege

Next Generation Sequencing Analysis in Early Onset Dementia Patients – Open Access
Bonvicini, Cristian | Scassellati, Catia | Benussi, Luisa | Di Maria, Emilio | Maj, Carlo | Ciani, Miriam | Fostinelli, Silvia | Mega, Anna | Bocchetta, Martina | Lanzi, Gaetana | Giacopuzzi, Edoardo | Ferraboli, Sergio | Pievani, Michela | Fedi, Virginia | Defanti, Carlo Alberto | Giliani, Silvia | Frisoni, Giovanni Battista | Ghidoni, Roberta | Gennarelli, Massimo

Vital Exhaustion and Incidence of Dementia: Results from the Copenhagen City Heart Study – Open Access
Islamoska, Sabrina | Ishtiak-Ahmed, Kazi | Hansen, Åse Marie | Grynderup, Matias Brødsgaard | Mortensen, Erik Lykke | Garde, Anne Helene | Gyntelberg, Finn | Prescott, Eva Irene Bossano | Török, Eszter | Waldemar, Gunhild | Nabe-Nielsen, Kirsten

Be sure to visit the Editors' Blog section of the JAD website to discover recent content:

Recent Advances in the Field of 3D Modelling for Neurodegeneration by Silvia Bolognin
In the last few years, we have witnessed a tremendous advancement in cell culturing methods. The scene has been dominated by the optimization of 3D in vitro models either in the form of dissociated neuronal cultures or of the so-called organoids. The attempt of introducing new methods responds to the difficulty of capturing the multifactorial nature of diseases such as Alzheimer’s and Parkinson’s diseases in conventional models.

Prion Protein and Alzheimer's Disease by Saima Zafar
Alzheimer's disease is the most prevalent form of dementia with large impact on population over the age of 65 years. The most distinctive symptomatic phase during the disease is the decline of the cognition with the loss of synapses. In recent years, there is debate on cellular form of PrP and its role in AD as a negative key player or protective modulator in-conjugation with amyloid-β oligomers.

What Does Music Therapy Look Like for Persons with AD? by Amy Clements-Cortes
This blog is a follow-up to the one I published in August 2017, titled “Music Experiences for Persons with AD”. In this piece, I am focusing on one of the experiences: Music Therapy. As an inexpensive, evidence-based, and non-pharmacological treatment, music therapy should highly be considered in the total care package for persons living with AD.

Alzheimer’s Disease, the Sweet Trail to Neuroprotection by Stefano Sensi
In Alzheimer’s disease, we are gaining great ground in the field of early diagnosis, but disease-modifying drugs are still missing. While many studies have been focused on the pathogenic role of amyloid-β dysmetabolism, recent preclinical and clinical findings revealed a more complex picture. In AD, we need to embrace a complex view of the disease state as a condition resulting from the converging failure of health-controlling systems and networks.

Visit J-Alz.com to read all posts